| Literature DB >> 22420884 |
Antonia F Stepan1, Chakrapani Subramanyam, Ivan V Efremov, Jason K Dutra, Theresa J O'Sullivan, Kenneth J DiRico, W Scott McDonald, Annie Won, Peter H Dorff, Charles E Nolan, Stacey L Becker, Leslie R Pustilnik, David R Riddell, Gregory W Kauffman, Bethany L Kormos, Liming Zhang, Yasong Lu, Steven H Capetta, Michael E Green, Kapil Karki, Evelyn Sibley, Kevin P Atchison, Andrew J Hallgren, Christine E Oborski, Ashley E Robshaw, Blossom Sneed, Christopher J O'Donnell.
Abstract
Replacement of the central, para-substituted fluorophenyl ring in the γ-secretase inhibitor 1 (BMS-708,163) with the bicyclo[1.1.1]pentane motif led to the discovery of compound 3, an equipotent enzyme inhibitor with significant improvements in passive permeability and aqueous solubility. The modified biopharmaceutical properties of 3 translated into excellent oral absorption characteristics (~4-fold ↑ C(max) and AUC values relative to 1) in a mouse model of γ-secretase inhibition. In addition, SAR studies into other fluorophenyl replacements indicate the intrinsic advantages of the bicyclo[1.1.1]pentane moiety over conventional phenyl ring replacements with respect to achieving an optimal balance of properties (e.g., γ-secretase inhibition, aqueous solubility/permeability, in vitro metabolic stability). Overall, this work enhances the scope of the [1.1.1]-bicycle beyond that of a mere "spacer" unit and presents a compelling case for its broader application as a phenyl group replacement in scenarios where the aromatic ring count impacts physicochemical parameters and overall drug-likeness.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22420884 DOI: 10.1021/jm300094u
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446